COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

NRX101 for Moderate Bipolar Depression and Suicidal Ideation (MBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03395392
Recruitment Status : Not yet recruiting
First Posted : January 10, 2018
Last Update Posted : December 19, 2018
Target Health Inc.
Bracket, Inc.
Statistics Collaborative, Inc.
Information provided by (Responsible Party):
NeuroRx, Inc.

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 31, 2019
Estimated Study Completion Date : March 31, 2019